Clinical management and innovation in fracture nonunion.

Bone Fracture-related infection (FRI) bone healing fracture nonunion

Journal

Expert opinion on biological therapy
ISSN: 1744-7682
Titre abrégé: Expert Opin Biol Ther
Pays: England
ID NLM: 101125414

Informations de publication

Date de publication:
09 Aug 2024
Historique:
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 10 8 2024
Statut: aheadofprint

Résumé

With the introduction and continuous improvement in operative fracture fixation, even the most severe bone fractures can be treated with a high rate of successful healing. However, healing complications can occur and when healing fails over prolonged time, the outcome is termed a fracture nonunion. Nonunion is generally believed to develop due to inadequate fixation, underlying host-related factors or infection. Despite the advancements in fracture fixation and infection management, there is still a clear need for earlier diagnosis, improved prediction of healing outcomes and innovation in the treatment of nonunion. This review provides a detailed description of nonunion from a clinical perspective including state of the art in diagnosis, treatment, and currently available biomaterials and orthobiologics.Subsequently, recent translational development from the biological, mechanical and infection research fields are presented including the latest in smart implants, osteoinductive materials and The first challenge for future innovations is to refine and to identify new clinical factors for the proper definition, diagnosis and treatment of nonunion. However, integration of in vitro, in vivo, and in silico research will enable a comprehensive understanding of nonunion causes and correlations, leading to the development of more effective treatments.

Identifiants

pubmed: 39126182
doi: 10.1080/14712598.2024.2391491
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

C Siverino (C)

AO Research Institute Davos, Switzerland.

W-J Metsemakers (WJ)

Department of Trauma Surgery, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven - University of Leuven, Leuven, Belgium.

R Sutter (R)

Radiology Department, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.

E Della Bella (E)

AO Research Institute Davos, Switzerland.

M Morgenstern (M)

Center for Musculoskeletal Infections, Department of Orthopaedic and Trauma Surgery, University Hospital Basel, Switzerland.

J Barcik (J)

AO Research Institute Davos, Switzerland.

M Ernst (M)

AO Research Institute Davos, Switzerland.

M D'Este (M)

AO Research Institute Davos, Switzerland.

A Joeris (A)

AO Innovation Translation Center, Switzerland.

M Chittò (M)

AO Research Institute Davos, Switzerland.

P Schwarzenberg (P)

AO Research Institute Davos, Switzerland.

M Stoddart (M)

AO Research Institute Davos, Switzerland.

N Vanvelk (N)

Trauma Research Unit, Department of Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.

G Richards (G)

AO Research Institute Davos, Switzerland.

E Wehrle (E)

AO Research Institute Davos, Switzerland.
Institute for Biomechanics, ETH Zurich, Zurich, Switzerland.

F Weisemann (F)

Department of Trauma Surgery, BG Unfallklinik Murnau, Murnau am Staffelsee, Germany.

S Zeiter (S)

AO Research Institute Davos, Switzerland.

C Zalavras (C)

Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, USA.

P Varga (P)

AO Research Institute Davos, Switzerland.

T F Moriarty (TF)

AO Research Institute Davos, Switzerland.
Center for Musculoskeletal Infections, Department of Orthopaedic and Trauma Surgery, University Hospital Basel, Switzerland.

Classifications MeSH